F. Gail Bormel
View detailed information about F. Gail Bormel, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of Compounding Quality and Compliance.
Documents (18)
- WARNING LETTER · Tailstorm Health Inc. dba Medivant Health · October 10, 2024
- WARNING LETTER · Empower Clinic Services, LLC dba Empower Pharmacy · August 28, 2024
- WARNING LETTER · Exela Pharma Sciences LLC · November 15, 2024
- WARNING LETTER · Staska Pharmaceuticals, Inc. · September 18, 2024
- WARNING LETTER · ProRx, LLC · August 2, 2024
- WARNING LETTER · OSRX, Inc. · October 25, 2024
- WARNING LETTER · Fagron Compounding Services · June 28, 2024
- WARNING LETTER · Nubratori Inc. dba Nubratori Rx · July 26, 2024
- WARNING LETTER · Annovex Pharma, Inc · September 6, 2024
- WARNING LETTER · Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals · June 21, 2024
- WARNING LETTER · Exela Pharma Sciences, LLC · November 15, 2024
- WARNING LETTER · ProRx, LLC · August 2, 2024
- WARNING LETTER · Wells Pharma of Houston LLC · March 28, 2025
- WARNING LETTER · MedisourceRx · June 10, 2025
- WARNING LETTER · Turbare Manufacturing · January 24, 2025
- WARNING LETTER · Empower Clinic Services, LLC dba Empower Pharmacy · October 4, 2024
- WARNING LETTER · Revive Rx LLC dba Revive Rx Pharmacy · February 7, 2025
- UNTITLED LETTER · LEESAR, INC · April 29, 2025
Related Office
Person Information
Name
F. Gail Bormel
Title
F.
Role
Regulatory Personnel
ID: 9aba4201-9a1a-4db6-85ef-1f33dc50525d
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.